Evidence map›Paper›PMID 27009365›Full record

ArticleScientific reports2016

WIP and WICH/WIRE co-ordinately control invadopodium formation and maturation in human breast cancer cell invasion.

Esther García, Chiara Ragazzini, Xinzi Yu, Elena Cuesta-García, Jorge Bernardino de la Serna, Tobias Zech, David Sarrió, Laura M Machesky, Inés M Antón

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Esther GarcíaCentro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain.
Chiara RagazziniCentro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain.
Xinzi YuThe Beatson Institute for Cancer Research, Glasgow, UK.
Elena Cuesta-GarcíaCentro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain.
Jorge Bernardino de la SernaScience and Technology Facilities Council, Rutherford Appleton Laboratory, Central Laser Facility, Research Complex at Harwell, Harwell-Oxford, UK.
Tobias ZechThe Beatson Institute for Cancer Research, Glasgow, UK.
David SarrióUniversidad Autónoma de Madrid, Madrid, Spain.
Laura M MacheskyThe Beatson Institute for Cancer Research, Glasgow, UK.
Inés M AntónCentro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain.
Centro Nacional de Biotecnología · ESCancer Research UK Scotland Institute · GBScience and Technology Facilities Council · GBUniversidad Autónoma de Madrid · ES

Funding

Cancer Research UK 15673Medical Research Council G117/569Worldwide Cancer Research 11-0119
6 · The paper itself

Abstract

Cancer cells form actin-rich degradative protrusions (invasive pseudopods and invadopodia), which allows their efficient dispersal during metastasis. Using biochemical and advanced imaging approaches, we demonstrate that the N-WASP-interactors WIP and WICH/WIRE play non-redundant roles in cancer cell invasion. WIP interacts with N-WASP and cortactin and is essential for invadopodium assembly, whereas WICH/WIRE regulates N-WASP activation to control invadopodium maturation and degradative activity. Our data also show that Nck interaction with WIP and WICH/WIRE modulates invadopodium maturation; changes in WIP and WICH/WIRE levels induce differential distribution of Nck. We show that WIP can replace WICH/WIRE functions and that elevated WIP levels correlate with high invasiveness. These findings identify a role for WICH/WIRE in invasiveness and highlight WIP as a hub for signaling molecule recruitment during invadopodium generation and cancer progression, as well as a potential diagnostic biomarker and an optimal target for therapeutic approaches.

Indexed as

Breast NeoplasmsCarrier ProteinsCell Line, TumorCell MovementCortactinCytoskeletal ProteinsFemaleGene Expression Regulation, NeoplasticHumansIntracellular Signaling Peptides and ProteinsMicrofilament ProteinsNeoplasm InvasivenessPodosomesSignal TransductionWiskott-Aldrich Syndrome Protein, NeuronalCarrier ProteinsCortactinCTTN protein, humanCytoskeletal ProteinsIntracellular Signaling Peptides and ProteinsMicrofilament ProteinsWASL protein, humanWIPF1 protein, humanWIPF2 protein, humanWiskott-Aldrich Syndrome Protein, Neuronal

Identifiers

PMID27009365
PMCPMC4806363
OpenAlexW2302979357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.